Your browser doesn't support javascript.
loading
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma.
Spear, Melissa L; Hu, Donglei; Pino-Yanes, Maria; Huntsman, Scott; Eng, Celeste; Levin, Albert M; Ortega, Victor E; White, Marquitta J; McGarry, Meghan E; Thakur, Neeta; Galanter, Joshua; Mak, Angel C Y; Oh, Sam S; Ampleford, Elizabeth; Peters, Stephen P; Davis, Adam; Kumar, Rajesh; Farber, Harold J; Meade, Kelley; Avila, Pedro C; Serebrisky, Denise; Lenoir, Michael A; Brigino-Buenaventura, Emerita; Cintron, William Rodriguez; Thyne, Shannon M; Rodriguez-Santana, Jose R; Ford, Jean G; Chapela, Rocio; Estrada, Andrés Moreno; Sandoval, Karla; Seibold, Max A; Winkler, Cheryl A; Bleecker, Eugene R; Myers, Deborah A; Williams, L Keoki; Hernandez, Ryan D; Torgerson, Dara G; Burchard, Esteban G.
Afiliação
  • Spear ML; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
  • Hu D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Pino-Yanes M; Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, Tenerife, Spain.
  • Huntsman S; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
  • Eng C; Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, La Laguna, Tenerife, Spain.
  • Levin AM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Ortega VE; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • White MJ; Department of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
  • McGarry ME; Department of Internal Medicine, Wake Forest Baptist Medical Center, Winston Salem, NC, USA.
  • Thakur N; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Galanter J; Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Mak ACY; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Oh SS; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
  • Ampleford E; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Peters SP; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Davis A; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Kumar R; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Farber HJ; Department of Internal Medicine, Wake Forest Baptist Medical Center, Winston Salem, NC, USA.
  • Meade K; Department of Internal Medicine, Wake Forest Baptist Medical Center, Winston Salem, NC, USA.
  • Avila PC; UCSF Benioff Children's Hospital Oakland, Center for Community Health and Engagement, Oakland, CA, USA.
  • Serebrisky D; Ann & Robert H. Lurie Children's Hospital of Chicago, Pediatrics, Chicago, IL, USA.
  • Lenoir MA; Department of Pediatrics, Section of Pulmonology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Brigino-Buenaventura E; UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA.
  • Cintron WR; Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Thyne SM; Pediatric Pulmonary Division, Jacobi Medical Center, Bronx, NY, USA.
  • Rodriguez-Santana JR; Albert Einstein College of Medicine, Pediatrics, Bronx, NY, USA.
  • Ford JG; Bay Area Pediatrics, Oakland, CA, USA.
  • Chapela R; Department of Allergy & Immunology, Kaiser Permanente-Vallejo Medical Center, Vallejo, CA, USA.
  • Estrada AM; Veterans Caribbean Health System, San Juan, Puerto Rico.
  • Sandoval K; Department of Pediatrics, David Geffen School of Medicine at ULCA, Olive View-UCLA Medical Center, Sylmar, CA, USA.
  • Seibold MA; Centro de Neumologia Pediatrica, San Juan, Puerto Rico.
  • Winkler CA; Columbia University, New York, NY, USA.
  • Bleecker ER; Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
  • Myers DA; National Laboratory of Genomics for Biodiversity (LANGEBIO), CINVESTAV, Irapuato, Guanajuato, Mexico.
  • Williams LK; National Laboratory of Genomics for Biodiversity (LANGEBIO), CINVESTAV, Irapuato, Guanajuato, Mexico.
  • Hernandez RD; Department of Pediatrics, National Jewish Health, Denver, CO, USA.
  • Torgerson DG; Basic Research Laboratory, National Cancer Institute, Leidos Biomedical Research, Frederick National Laboratory, Frederick, MD, USA.
  • Burchard EG; Department of Medicine, The University of Arizona, Tucson, AZ, USA.
Pharmacogenomics J ; 19(3): 249-259, 2019 06.
Article em En | MEDLINE | ID: mdl-30206298
Short-acting ß2-adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the United States. However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma. To identify genetic variants that may contribute to differences in BDR in African Americans with asthma, we performed a genome-wide association study (GWAS) of BDR in 949 African-American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase III genotypes. We used linear regression models adjusting for age, sex, body mass index (BMI) and genetic ancestry to test for an association between BDR and genotype at single-nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1830 Latinos (total = 2779). Finally, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. We identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p = 7.69 × 10-9). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958 and rs7081864, p ≤ 5 × 10-8). Our results failed to replicate in three additional populations of 416 Latinos and 1615 African Americans. Our findings indicate that both population-specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos